Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Recruiting now · Phase 2
Conditions studied: Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension
In brief
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published regimens in SSc patients, while maintaining a treatment effect.
Key facts
- Study ID
- NCT03630211
- Run by
- Paul Szabolcs
- People needed
- 8
- Starts
- 2018-07-31
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2025-10-15
Who can join
Age: 8 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States (enrolling)
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States (enrolling)
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.